A New hybrid radiotherapy technique for non-small cell lung cancer: Is more effective for functional lung sparing

被引:0
作者
Chen, C. [1 ]
Chen, G. [1 ]
Fang, R. [1 ]
Xu, Y. [1 ]
Liu, H. [1 ]
Liao, Z. [1 ]
机构
[1] Wuhan Univ, Zhongnan Hosp, Hubei Canc Clin Study Ctr, Hubei Key Lab Tumor Biol Behav,Dept Radiat & Med O, Wuhan 430071, Hubei, Peoples R China
来源
INTERNATIONAL JOURNAL OF RADIATION RESEARCH | 2024年 / 22卷 / 03期
关键词
carcinoma; three dimensional conformal; radiotherapy; intensity-modulated; MODULATED RADIATION-THERAPY; ARC THERAPY; IMAGE REGISTRATION; VENTILATION; PNEUMONITIS; IMRT; VMAT; REDUCTION;
D O I
10.61186/ijrr.22.3.609
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background: The Conventional thoracic radiotherapy planning ignores regional pulmonary function changes. This study aimed to evaluate the beneficial effect of a new hybrid three-dimensional conformal radiation therapy (3DCRT)/intensitymodulated radiation therapy (IMRT) technique. Materials and Methods: Thirty patients with non-small cell lung cancer were included in this study. Four protocols were designed for each patient: anatomical IMRT (A-IMRT, based on the total lung), functional IMRT (F-IMRT), pure IMRT (O-IMRT) plan, and hybrid 3DCRT/IMRT plan (H3DCRT/IMRT), which were based on the functional lung. The opposing pair of fields in the O-IMRT and H-3DCRT/IMRT protocols provide 2/9 and 1/2 of radiation dose, respectively. The planning target volume coverage, dose in both total and functional lungs, maximum spinal cord dose, mean esophagus dose, mean heart dose, homogeneity index (HI), conformity index (CI), and treatment monitor units (MUs) were compared in this study. Results: The V5, V20, and mean dose (Dmean) of the both total and functional lungs in the H-3DCRT/IMRT protocol were the lowest among the four treatment regimes. For D2, D98, HI, and CI, the A-IMRT protocol was superior to the H-3DCRT/IMRT protocol. Compared with the A-IMRT protocol, the F-IMRT protocol achieved significantly lower V5, V20, and Dmean for functional lungs, but showed worse HI, CI, and maximum dose of spinal cord. The H-3DCRT/IMAT protocol significantly reduced the maximum spinal cord dose and MUs. Conclusions: The H-3DCRT/IMAT plan based on functional lung images appeared to be better than conventional F-IMRT in preserving functional lung without compromising on HI and CI in NSCLC patients.
引用
收藏
页码:609 / 616
页数:8
相关论文
共 50 条
  • [31] The effect of radiotherapy on the survival of non-small cell lung cancer patients
    Schaafsma, J
    Coy, P
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 41 (02): : 291 - 298
  • [32] Carbon-ion radiotherapy for non-small cell lung cancer with interstitial lung disease: a retrospective analysis
    Nakajima, Mio
    Yamamoto, Naoyoshi
    Hayashi, Kazuhiko
    Karube, Masataka
    Ebner, Daniel K.
    Takahashi, Wataru
    Anzai, Makoto
    Tsushima, Kenji
    Tada, Yuji
    Tatsumi, Koichiro
    Miyamoto, Tadaaiki
    Tsuji, Hiroshi
    Fujisawa, Takehiko
    Kamada, Tadashi
    RADIATION ONCOLOGY, 2017, 12
  • [33] High-dose hyperfractionated accelerated radiotherapy in non-small cell lung cancer
    De Ruysscher, D.
    Reymen, B.
    Van Baardwijk, A.
    MINERVA CHIRURGICA, 2011, 66 (04) : 341 - 345
  • [34] Radiotherapy issues in non-small cell lung cancer: radiotherapy versus surgery in the treatment of early stage
    Jimenez, M. F.
    Varela, G.
    Van Baardwijk, A.
    De Ruysscher, D.
    MINERVA CHIRURGICA, 2011, 66 (03) : 245 - 250
  • [35] Concurrent chemoradiotherapy in non-small cell lung cancer
    O'Rourke, Noelle
    Roque i Figuls, Marta
    Farre Bernado, Nuria
    Macbeth, Fergus
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (06):
  • [36] Functional image-based radiotherapy planning for non-small cell lung cancer: A simulation study
    Bates, Emma L.
    Bragg, Christopher M.
    Wild, Jim M.
    Hatton, Matthew Q. F.
    Ireland, Rob H.
    RADIOTHERAPY AND ONCOLOGY, 2009, 93 (01) : 32 - 36
  • [37] New Targeted Therapy for Non-Small Cell Lung Cancer
    Chung, Eun Ki
    Yong, Seung Hyun
    Lee, Eun Hye
    Kim, Eun Young
    Chang, Yoon Soo
    Lee, Sang Hoon
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2023, 86 (01) : 1 - 13
  • [38] New targets and new treatments in non-small cell lung cancer
    Johnson, BE
    EJC SUPPLEMENTS, 2004, 2 (04): : 1 - 6
  • [39] Prognosis factors after lung stereotactic body radiotherapy for non-small cell lung carcinoma
    Yossi, S.
    Nguyen, D.
    Krhili, S.
    Lizee, T.
    Khodri, M.
    CANCER RADIOTHERAPIE, 2020, 24 (03): : 267 - 274
  • [40] Radiotherapy for stage I-II non-small cell lung cancer
    Okamoto Y.
    Murakami M.
    Mizowaki T.
    Nakajima T.
    Kuroda Y.
    International Journal of Clinical Oncology, 1999, 4 (6) : 372 - 377